No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol (Q44109803)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2005
edit
Language Label Description Also known as
English
No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol
scientific article published in September 2005

    Statements

    No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol (English)
    Shunji Igarashi
    Akira Ohara
    Masaaki Kumagai
    Tomohiro Saito
    Yuri Okimoto
    Takehiko Kamijo
    Keiichi Isoyama
    Michiko Kajiwara
    Manabu Sotomatsu
    Ken-ichi Sugita
    Kanji Sugita
    Miho Maeda
    Hiromasa Yabe
    Akitoshi Kinoshita
    Takashi Kaneko
    Yasuhide Hayashi
    Kouichiro Ikuta
    Ryohji Hanada
    Masahiro Tsuchida
    1 September 2005
    6489-6498

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit